Jackson Square Capital’s Gilead Sciences GILD Stock Holding History

Jackson Square Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.62M	Buy	18,785 +10,334	+122%	+$1.45M	0.55%	46
2025 Q4	$1.04M	Buy	+8,451	New	+$1.03M	0.21%	70
2025 Q3	–	Sell	-6,850	Closed	-$760K	–	152
2025 Q2	$760K	Sell	6,850 -1,161	-14%	-$124K	0.17%	93
2025 Q1	$898K	Buy	8,011 +5,762	+256%	+$595K	0.29%	66
2024 Q4	$208K	Buy	+2,249	New	+$202K	0.05%	141
2024 Q2	–	Sell	-14,192	Closed	-$1.04M	–	138
2024 Q1	$1.04M	Sell	14,192 -137	-1%	-$10.5K	0.27%	67
2023 Q4	$1.16M	Buy	14,329 +51	+0.4%	+$3.97K	0.37%	55
2023 Q3	$1.07M	Buy	14,278 +638	+5%	+$49.1K	0.43%	47
2023 Q2	$1.05M	Buy	13,640 +199	+1%	+$15.9K	0.42%	53
2023 Q1	$1.12M	Buy	13,441 +185	+1%	+$15.3K	0.5%	48
2022 Q4	$1.14M	Buy	+13,256	New	+$1.05M	0.54%	50
2020 Q4	–	Sell	-860	Closed	-$54K	–	216
2020 Q3	$54K	Hold	860	–	–	0.02%	174
2020 Q2	$66K	Hold	860	–	–	0.03%	151
2020 Q1	$64K	Hold	860	–	–	0.05%	111
2019 Q4	$56K	Buy	+860	New	+$56K	0.03%	147

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jackson Square Capital's GILD Position: Q1 2026 in Review

Jackson Square Capital increased its Gilead Sciences (GILD) stake by 122% in Q1 2026, buying an estimated $1.45M and bringing the position to 18,785 shares worth $2.62M. The position accounts for 0.55% of the portfolio, ranked #46.

Jackson Square Capital first reported a position in GILD in Q4 2019 and has held it in 15 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Jackson Square Capital held 18,785 shares of Gilead Sciences worth $2.62M as of Q1 2026.
Jackson Square Capital bought 10,334 Gilead Sciences shares in Q1 2026, an estimated $1.45M.
Gilead Sciences made up 0.55% of Jackson Square Capital's portfolio in Q1 2026, its #46 holding.
Jackson Square Capital first reported a position in Gilead Sciences in Q4 2019 and has held it in 15 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Jackson Square Capital's 13F filing for Q1 2026, filed 13 Apr 2026.